Product Information

CAS No.	2060571-02-8
Product Name	Inavolisib

Biological Targets

PIK3CA

Associated Conditions

breast cancer·endometrial cancer·neoplasm·cancer

* The information provided here is compiled from public sources and is for reference only.

Studies related to this compound and its mechanism of action

Preclinical assessment of the PI3Kα selective inhibitor inavolisib and prediction of its pharmacokinetics and efficacious dose in human.

Xenobiotica; the fate of foreign compounds in biological systems • Vol. 54, Issue 10 • 2024

PMID: 39387185 DOI: 10.1080/00498254.2024.2415103

Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα.

Journal of medicinal chemistry • Vol. 65, Issue 24 • 2022

PMID: 36455032 DOI: 10.1021/acs.jmedchem.2c01422

Importance of SH groups in catalysis by bovine brain acid phosphatase.

Biochimica et biophysica acta • Vol. 438, Issue 1 • 1976

PMID: 7316 DOI: 10.1016/0005-2744(76)90231-x

[Comparison of the endocrine response under 2 kinds of anesthesia: neuroleptanalgesia of the chlorprothixene-dextromoramide type and venous anesthesia of the type alfadione-fentanyl].

Annales de l'anesthesiologie francaise • Vol. 16, Issue 9 • 1975

PMID: 5035

Inavolisib

CAS No.	2060571-02-8
MDL No.	MFCD31382124
MF	C₁₈H₁₉F₂N₅O₄
MW	407.40
InChI Key	SGEUNORSOZVTOL-CABZTGNLSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	2060571-02-8
Product Name	Inavolisib

Biological Targets

PIK3CA

Associated Conditions

breast cancer·endometrial cancer·neoplasm·cancer

* The information provided here is compiled from public sources and is for reference only.

Inavolisib

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Inavolisib

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Inavolisib

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Preclinical assessment of the PI3Kα selective inhibitor inavolisib and prediction of its pharmacokinetics and efficacious dose in human.

Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα.

Importance of SH groups in catalysis by bovine brain acid phosphatase.

[Comparison of the endocrine response under 2 kinds of anesthesia: neuroleptanalgesia of the chlorprothixene-dextromoramide type and venous anesthesia of the type alfadione-fentanyl].

Inavolisib

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Preclinical assessment of the PI3Kα selective inhibitor inavolisib and prediction of its pharmacokinetics and efficacious dose in human.

Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα.

Importance of SH groups in catalysis by bovine brain acid phosphatase.

[Comparison of the endocrine response under 2 kinds of anesthesia: neuroleptanalgesia of the chlorprothixene-dextromoramide type and venous anesthesia of the type alfadione-fentanyl].

Documentation